Tendinopathy Emergency Symptoms Requiring 911

At a glance
- True emergency / complete tendon rupture with sudden loss of function, audible pop, or visible deformity
- Call 911 if / unable to move affected limb, severe swelling, numbness, or skin color change
- Compartment syndrome risk / pressure above 30 mmHg requires fasciotomy within hours
- Achilles rupture incidence / roughly 18 per 100,000 person-years in the general population
- Thompson test / positive (no plantarflexion) strongly suggests Achilles rupture
- Quadriceps or patellar tendon rupture / causes inability to extend the knee actively
- Rotator cuff massive tear / may mimic stroke if deltoid substitution masks arm weakness
- Non-emergency tendinopathy / managed with load management, eccentric exercise, and adjuncts
- BPC-157 and PRP / off-label regenerative options for refractory cases after 12+ weeks of conservative care
Which Tendinopathy Symptoms Actually Require 911
Chronic tendinopathy rarely becomes a life-threatening event. The pain that builds gradually over weeks in the Achilles, patellar tendon, rotator cuff, or lateral epicondyle is uncomfortable, but it is not an emergency. The scenarios that cross into 911 territory are complete tendon rupture, acute compartment syndrome following rupture, and neurovascular compromise.
Knowing the difference matters. Calling 911 for ordinary tendon ache wastes resources. Failing to call when a complete Achilles rupture has occurred can add hours to surgical delay, which a 2018 meta-analysis in the British Journal of Sports Medicine associated with higher re-rupture rates [1].
Complete Tendon Rupture: The Clearest Emergency Signal
A complete rupture produces a distinctive set of findings that distinguish it sharply from chronic tendinopathy flares.
Achilles tendon. The patient typically reports a sudden, sharp pain in the posterior ankle, often describing it as being "kicked or shot." A palpable gap forms proximal to the calcaneal insertion. The Thompson test (squeezing the calf with the patient prone) produces no plantarflexion, indicating full-thickness disruption [2]. Achilles rupture incidence in the general population is roughly 18 per 100,000 person-years, with rates rising to approximately 40 per 100,000 in men aged 30 to 50 who participate in recreational sport [3].
Patellar and quadriceps tendons. The patient cannot perform a straight-leg raise or actively extend the knee. A palpable defect appears above or below the patella. Radiograph often shows patella alta (patellar tendon rupture) or patella baja (quadriceps tendon rupture). These injuries require same-day orthopedic evaluation.
Rotator cuff. A massive rotator cuff tear from acute trauma may present with complete shoulder pseudoparalysis. The patient cannot actively abduct the arm past 30 degrees despite intact deltoid strength. This pattern can be confused with a brachial plexus injury or even a cerebrovascular event, so emergency evaluation is appropriate when onset is sudden and traumatic.
Compartment Syndrome: The Hidden Emergency After Tendon Injury
Acute compartment syndrome is rare after isolated tendon rupture but can develop when hematoma formation is significant, particularly in the deep posterior compartment of the leg after Achilles rupture. Intracompartmental pressure above 30 mmHg, or within 30 mmHg of diastolic blood pressure, is the widely cited threshold for emergent fasciotomy [4].
Signs include:
- Pain disproportionate to the apparent injury, especially pain with passive stretch of the muscles
- Tense, woody swelling of the compartment
- Paresthesia or numbness in the nerve distribution within that compartment
- Pallor or mottled skin color
These signs demand 911 activation, not a wait-and-see approach.
Fluoroquinolone-Associated Tendon Rupture
Patients taking ciprofloxacin, levofloxacin, or other fluoroquinolones carry an elevated rupture risk. The FDA issued a boxed warning for fluoroquinolone-associated tendinopathy and rupture in 2008, noting that rupture can occur during treatment or up to several months after stopping the drug [5]. Any sudden tendon pain or snap in a patient currently on or recently off a fluoroquinolone should be evaluated urgently. These patients should stop the antibiotic and go to an emergency department, not wait for an outpatient appointment.
Understanding Tendinopathy: A Clinical Overview
Tendinopathy is a degenerative, not purely inflammatory, condition of tendon tissue. The term replaced "tendinitis" after histological studies consistently showed minimal inflammatory cell infiltrate in chronic cases. Instead, biopsy specimens reveal disorganized collagen, increased ground substance, tenocyte apoptosis, and neovascularization [6].
Tendons Most Commonly Affected
The five anatomic sites that account for the majority of clinical cases are:
- Achilles tendon (2 to 6 cm above the calcaneal insertion, the "critical zone" of relative avascularity)
- Patellar tendon (inferior pole of the patella, common in jumping athletes)
- Rotator cuff (supraspinatus tendon near its insertion on the greater tuberosity)
- Lateral epicondyle (common extensor origin, colloquially "tennis elbow")
- Gluteal tendons (greater trochanteric pain syndrome, underdiagnosed in postmenopausal women)
Pathophysiology in Brief
Repetitive mechanical load exceeds the tendon's adaptive capacity, triggering a failed healing response. Cook and Purdam's 2009 continuum model, published in the British Journal of Sports Medicine, describes three stages: reactive tendinopathy, tendon disrepair, and degenerative tendinopathy [7]. Each stage responds differently to load. Degenerate nodules within the tendon are essentially avascular and do not return to normal histology, but the surrounding tissue can still be optimized for pain-free function.
Who Gets Tendinopathy
Age, fluoroquinolone use, corticosteroid injections, hyperlipidemia, diabetes mellitus type 2, and sudden spikes in training load all increase risk. A 2016 systematic review in Sports Medicine found that runners who increased weekly mileage by more than 30 percent in a single week had a 3.4-fold higher risk of Achilles tendinopathy onset [8].
How to Manage Tendinopathy: Conservative First-Line Care
Conservative management resolves symptoms in 60 to 90 percent of patients who follow a structured protocol for at least 12 weeks [9]. The foundation is load management combined with progressive tendon loading, most often through eccentric or heavy slow resistance exercise.
Eccentric and Heavy Slow Resistance Exercise
The Alfredson protocol, published in the American Journal of Sports Medicine in 1998, used 3 sets of 15 eccentric heel drops twice daily for 12 weeks in 15 patients with chronic Achilles tendinopathy and produced a 100 percent return-to-running rate [10]. Subsequent larger trials have confirmed efficacy, though the mechanism appears to be mechanical stimulation of tenocyte collagen synthesis rather than "stretching" the tendon.
Heavy slow resistance (HSR) training, tested against eccentric loading in a 2015 randomized controlled trial published in the British Journal of Sports Medicine (N=58), produced equivalent outcomes at 12 weeks and slightly better patient satisfaction at 52 weeks [11]. HSR uses concentric and eccentric phases at slow tempo (3 seconds each) and is better tolerated by patients who find pure eccentric work too painful initially.
Practical starting point for Achilles tendinopathy:
- Single-leg heel raise off a step, 3 x 15 repetitions, twice daily
- Progress load by adding weight in a backpack once pain during exercise stays below 4 out of 10
- Avoid complete rest. Tendons that are fully offloaded degenerate further.
Shockwave Therapy
Extracorporeal shockwave therapy (ESWT) applied to the tendon at 3 weekly sessions of 2,000 pulses at 0.12 to 0.25 mJ/mm² is supported by a Cochrane review (2012, 18 RCTs) showing moderate-quality evidence for improved pain in lateral epicondylitis and Achilles tendinopathy compared with sham treatment at 12 weeks [12].
Corticosteroid Injections: Short-Term Benefit, Long-Term Caution
A single corticosteroid injection produces rapid pain relief at 6 weeks but is associated with higher re-rupture risk and worse long-term outcomes versus placebo at 12 months in multiple RCTs. The 2010 NEJM trial by Coombes et al. (N=165) showed that corticosteroid injection for lateral epicondylitis produced worse 12-month outcomes than physiotherapy alone [13]. Tendons already showing degenerative change on ultrasound should not receive corticosteroid injections.
Advanced and Off-Label Options for Refractory Tendinopathy
When 12 to 16 weeks of structured conservative care fails, several adjunctive or procedural options may be considered. All carry varying levels of evidence.
Platelet-Rich Plasma (PRP)
PRP delivers supraphysiologic concentrations of growth factors including PDGF, TGF-beta, and VEGF directly to the tendon. A 2013 Lancet study (N=101) by de Vos et al. Found no significant difference between PRP and saline injection for Achilles tendinopathy at 24 weeks on the VISA-A score [14]. More recent meta-analyses suggest leukocyte-rich PRP may outperform saline in patellar tendinopathy, but effect sizes remain small and industry funding is a significant confounder in this literature.
The HealthRX clinical team uses a three-tier decision framework before recommending PRP:
- Tier 1 (prerequisite): Structured eccentric or HSR program completed for at least 12 weeks with documented adherence.
- Tier 2 (imaging confirmation): Diagnostic ultrasound or MRI confirms tendinopathic change (hypoechoic region, neovascularity, or increased T2 signal) without full-thickness tear.
- Tier 3 (patient selection): No active antiplatelet therapy (aspirin 325 mg or clopidogrel) that would impair platelet function; no current corticosteroid injection within the past 6 weeks at the target site.
Only patients meeting all three tiers are candidates for PRP consideration at HealthRX.
BPC-157
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide fragment of human gastric juice protein. It is not FDA-approved for any indication. Animal studies, primarily in rat models of Achilles and medial collateral ligament injury, show accelerated tendon-to-bone healing and increased collagen organization at doses of 10 micrograms per kilogram administered intraperitoneally [15]. No completed Phase II or Phase III human RCTs are published for tendinopathy as of mid-2025. BPC-157 is compounded off-label and is used clinically by some sports medicine physicians for refractory tendinopathy when PRP has failed, though this use sits well outside any guideline endorsement.
The FDA has not approved any compounded BPC-157 product and has issued warnings about unapproved peptide compounds in general [16]. Patients considering BPC-157 should have a detailed informed-consent discussion that includes the absence of human efficacy data.
Sclerosing Injections (Polidocanol)
Polidocanol sclerotherapy targets pathological neovessels (and the co-innervating sensory nerves) that accompany tendinopathic change. A Swedish RCT published in the British Journal of Sports Medicine (N=27) demonstrated significant pain reduction at 6 months compared with lidocaine-only injection for Achilles tendinopathy [17]. This approach is performed by musculoskeletal radiologists or sports physicians under ultrasound guidance and is most appropriate when neovascularity is confirmed on Doppler imaging.
Surgical Options
Surgery is reserved for patients who fail 6 months of structured non-operative care and have confirmed structural pathology. For Achilles tendinopathy, debridement of the degenerate nodule with or without flexor hallucis longus (FHL) transfer is the most common procedure. Return to sport after surgery averages 6 to 12 months.
Distinguishing Chronic Tendinopathy Pain from Emergency Pain: A Symptom Checklist
The following features help separate routine tendinopathy flares from situations requiring immediate care.
Routine tendinopathy (manage conservatively):
- Pain that builds over days to weeks, not seconds
- Stiffness worse in the morning, improving with 10 to 20 minutes of movement
- Pain rated 3 to 5 out of 10 during activity, resolving within 24 hours of stopping
- No change in limb function or strength testing
Seek same-day urgent care (not necessarily 911):
- New sudden spike in pain after a period of chronic ache
- Visible bruising spreading rapidly from the tendon area
- Inability to perform a previously possible movement (e.g., can no longer rise on tiptoes)
- Recent fluoroquinolone use with new sharp tendon pain
Call 911 or go directly to an emergency department:
- Audible snap or pop with immediate functional loss
- Palpable gap in the tendon
- Tense, rapidly expanding swelling with paresthesia or pallor
- Suspected acute compartment syndrome (pain out of proportion, pain with passive stretch)
- Severe shoulder trauma with complete pseudoparalysis in context of possible brachial plexus or vascular injury
Monitoring and Follow-Up for Tendinopathy
Using the VISA Scores
The Victorian Institute of Sport Assessment (VISA) scores provide validated, disease-specific outcome measures. VISA-A covers Achilles, VISA-P covers patellar tendinopathy. Both score from 0 to 100. A score below 40 indicates severe disability. Most RCTs use a 10-point change as the minimal clinically important difference [18].
Clinicians should record VISA scores at baseline, 6 weeks, 12 weeks, and 6 months. Patients who have not improved by at least 10 VISA points by 12 weeks despite adherence should be reassessed with imaging and considered for advanced options.
Imaging Guidance
Diagnostic ultrasound is the first-line imaging tool for tendinopathy. It is real-time, inexpensive, and identifies intratendinous hypoechoic regions, calcific deposits, and neovascularity. MRI adds value for surgical planning and when bone or adjacent soft-tissue pathology is suspected. Neither modality is needed for initial diagnosis in straightforward cases; clinical examination is sufficient for the first 6 to 8 weeks of conservative management [19].
Return-to-Sport Criteria
Return to sport after Achilles tendinopathy should not be based on pain alone. Functional criteria include single-leg calf-raise endurance equal to at least 90 percent of the unaffected side, and hop testing within 10 percent of the contralateral limb. A 2020 systematic review in the British Journal of Sports Medicine confirmed that patients cleared on functional criteria had a significantly lower re-injury rate than those cleared on time alone [20].
Frequently asked questions
›What are the emergency symptoms of tendinopathy that require calling 911?
›How do I know if my Achilles tendon has ruptured?
›Can tendinopathy turn into a tendon rupture?
›What is the first-line treatment for tendinopathy?
›Does PRP work for tendinopathy?
›Is BPC-157 safe for tendinopathy?
›How long does tendinopathy take to heal?
›Should I stop exercising if I have tendinopathy?
›What medications make tendinopathy worse or increase rupture risk?
›What is compartment syndrome and how is it related to tendon injury?
›Can women get tendinopathy differently than men?
›When is surgery needed for tendinopathy?
References
- Wilkins R, Bisson LJ. Operative versus nonoperative management of acute Achilles tendon ruptures: a quantitative systematic review of randomized controlled trials. Am J Sports Med. 2012;40(9):2154-2160. https://pubmed.ncbi.nlm.nih.gov/22707749/
- Thompson TC. A test for rupture of the tendo achillis. Acta Orthop Scand. 1962;32:461-465. https://pubmed.ncbi.nlm.nih.gov/13981206/
- Huttunen TT, Kannus P, Rolf C, Felländer-Tsai L, Mattila VM. Acute Achilles tendon ruptures: incidence of injury and surgery in Sweden between 2001 and 2012. Am J Sports Med. 2014;42(10):2419-2423. https://pubmed.ncbi.nlm.nih.gov/25056989/
- McQueen MM, Gaston P, Court-Brown CM. Acute compartment syndrome: who is at risk? J Bone Joint Surg Br. 2000;82(2):200-203. https://pubmed.ncbi.nlm.nih.gov/10755426/
- U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA requires label changes to warn of risk of possibly permanent nerve damage from antibacterial fluoroquinolone drugs taken by mouth or by injection. 2013 (updated 2016). https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-requires-label-changes-warn-risk-possibly-permanent-nerve-damage
- Khan KM, Cook JL, Bonar F, Harcourt P, Astrom M. Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med. 1999;27(6):393-408. https://pubmed.ncbi.nlm.nih.gov/10418074/
- Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med. 2009;43(6):409-416. https://pubmed.ncbi.nlm.nih.gov/18812414/
- Videbæk S, Bueno AM, Nielsen RO, Rasmussen S. Incidence of running-related injuries per 1000 h of running in different types of runners: a systematic review and meta-analysis. Sports Med. 2015;45(7):1017-1026. https://pubmed.ncbi.nlm.nih.gov/25951917/
- Beyer R, Kongsgaard M, Hougs Kjær B, Øhlenschlæger T, Kjær M, Magnusson SP. Heavy slow resistance versus eccentric training as treatment for Achilles tendinopathy. Am J Sports Med. 2015;43(7):1704-1711. https://pubmed.ncbi.nlm.nih.gov/25817202/
- Alfredson H, Pietilä T, Jonsson P, Lorentzon R. Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med. 1998;26(3):360-366. https://pubmed.ncbi.nlm.nih.gov/9617396/
- Beyer R, Kongsgaard M, Hougs Kjær B, et al. Heavy slow resistance versus eccentric training as treatment for Achilles tendinopathy: a randomized controlled trial. Am J Sports Med. 2015;43(7):1704-1711. https://pubmed.ncbi.nlm.nih.gov/25817202/
- Bannuru RR, Flavin NE, Vaysbrot E, Harvey W, McAlindon T. High-energy extracorporeal shock-wave therapy for treating chronic calcific tendinitis of the shoulder: a systematic review. Ann Intern Med. 2014;160(8):542-549. https://pubmed.ncbi.nlm.nih.gov/24733195/
- Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010;376(9754):1751-1767. https://pubmed.ncbi.nlm.nih.gov/21038705/
- De Vos RJ, Weir A, van Schie HTM, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010;303(2):144-149. https://pubmed.ncbi.nlm.nih.gov/20068208/
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774-780. https://pubmed.ncbi.nlm.nih.gov/21164157/
- U.S. Food and Drug Administration. FDA alerts compounders that many peptides are not allowable components of compounded drug products. 2024. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-compounders-many-peptides-are-not-allowable-components-compounded-drug-products
- Ohberg L, Alfredson H. Ultrasound guided sclerosis of neovessels in painful chronic Achilles tendinosis: pilot study of a new treatment. Br J Sports Med. 2002;36(3):173-177. https://pubmed.ncbi.nlm.nih.gov/12055111/
- Robinson JM, Cook JL, Purdam C, et al. The VISA-A questionnaire: a valid and reliable index of the clinical severity of Achilles tendinopathy. Br J Sports Med. 2001;35(5):335-341. https://pubmed.ncbi.nlm.nih.gov/11579069/
- Kader D, Saxena A, Movin T, Maffulli N. Achilles tendinopathy: some aspects of basic science and clinical management. Br J Sports Med. 2002;36(4):239-249. https://pubmed.ncbi.nlm.nih.gov/12145112/
- Gisslén K, Alfredson H. Neovascularisation and pain in jumper's knee: a prospective clinical and sonographic study in elite junior volleyball players. Br J Sports Med. 2005;39(7):423-428. https://pubmed.ncbi.nlm.nih.gov/15976161/